113 results
Page 2 of 6
8-K
EX-99.1
kta8j3la5p2z
10 Jul 23
Regulation FD Disclosure
4:06pm
8-K
EX-99.1
rjb1 kn9bmpvp00
9 May 23
Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2023 Financial Results
4:06pm
8-K
EX-99.1
bym46
3 May 23
Soleno Therapeutics Completes Enrollment in Randomized Withdrawal Period of Study C602 of DCCR for Prader-Willi Syndrome
5:26pm
8-K
yc7r3ep49rxa1jepv
19 Dec 22
Soleno Therapeutics Announces Financing Commitment for up to $60 Million
4:49pm
8-K
EX-99.1
fccete jwl5u
9 Nov 22
Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2022 Financial Results
4:11pm
8-K
EX-99.1
34mlsp 4uhp
10 Aug 22
Soleno Therapeutics Provides Corporate Update and Reports Second Quarter 2022 Financial Results
4:06pm
8-K/A
r3x2bpgy
25 Jul 22
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
EX-99.1
uhjo pd9gol9
10 May 22
Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2022 Financial Results
4:01pm
424B5
axjqntdhrvau6m
30 Mar 22
Prospectus supplement for primary offering
5:21pm
424B5
29lnk7yt
28 Mar 22
Prospectus supplement for primary offering
4:53pm